Millennium Management Portfolio holdings
Millennium Management, founded in 1989 by Israel (Izzy) Englander and Ronald Shear and headquartered in New York City, is a global multi-strategy hedge fund managing over $71 billion in assets as of late 2024, employing a decentralized model with over 300 independent trading teams. Operating across equities, fixed income, commodities, currencies, and derivatives, the firm uses a mix of quantitative and fundamental strategies, providing its portfolio managers with capital, infrastructure, and autonomy to pursue diverse investment approaches while enforcing strict risk management. With more than 5,400 employees across offices in London, Hong Kong, Singapore, and beyond, Millennium has evolved from its initial $35 million seed capital—partly from the Belzberg family—into a titan of the hedge fund world, known for its ability to attract top talent and deliver consistent returns. Under Englander’s leadership as chairman and CEO, the firm remains a low-profile yet highly influential force in global finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$643M |
| 2 |
AT&T
T
|
+$311M |
| 3 |
State Street Technology Select Sector SPDR ETF
XLK
|
+$306M |
| 4 |
Microsoft
MSFT
|
+$292M |
| 5 |
Ametek
AME
|
+$215M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$887M |
| 2 |
Apple
AAPL
|
+$694M |
| 3 |
PRAH
PRA Health Sciences, Inc.
PRAH
|
+$616M |
| 4 |
Amazon
AMZN
|
+$596M |
| 5 |
Linde
LIN
|
+$531M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 7.39% |
| 2 | Financials | 6.67% |
| 3 | Healthcare | 6.18% |
| 4 | Industrials | 4.97% |
| 5 | Consumer Discretionary | 4.39% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2951
MINISO
MNSO
$3.88B
| $4.45M | ﹤0.01% |
292,088
+185,163
| +173% | +$2.83M |
|
2952
Devon Energy
DVN
$52.1B
| $4.45M | ﹤0.01% |
125,330
-852,009
| -87% | -$24.2M |
|
|
CNBKA
2953
DELISTED
Century Bancorp Inc/Mass
CNBKA
| $4.45M | ﹤0.01% |
38,599
+10,761
| +39% | +$1.23M |
|
|
ISLE
2954
DELISTED
Isleworth Healthcare Acquisition Corporation Common stock
ISLE
| $4.44M | ﹤0.01% |
452,084
+53,611
| +13% | +$523K |
|
|
SCLEU
2955
DELISTED
Broadscale Acquisition Corp. Units
SCLEU
| $4.44M | ﹤0.01% |
449,103
-546,597
| -55% | -$5.43M |
|
|
PPL
2956
PPL Corp
PPL
$26.5B
| $4.44M | ﹤0.01% |
159,110
-2,597,605
| -94% | -$74.9M |
|
2957
Interparfums
IPAR
$3.99B
| $4.43M | ﹤0.01% |
59,285
-12,320
| -17% | -$901K |
|
|
MPT
2958
PUT
Medical Properties Trust
MPT
$2.77B
| $4.43M | ﹤0.01% |
+220,900
| New | +$4.53M |
|
2959
PUT
IQVIA
IQV
$38.7B
| $4.43M | ﹤0.01% |
18,500
-16,100
| -47% | -$4.06M |
|
2960
WD-40
WDFC
$3.05B
| $4.43M | ﹤0.01% |
19,134
+2,208
| +13% | +$530K |
|
|
FLAC
2961
DELISTED
Frazier Lifesciences Acquisition Corporation Class A Ordinary Shares
FLAC
| $4.43M | ﹤0.01% |
450,862
+218,000
| +94% | +$2.13M |
|
2962
CALL
Constellation Brands
STZ
$22.2B
| $4.42M | ﹤0.01% |
21,000
-187,200
| -90% | -$40.9M |
|
|
LDHAU
2963
DELISTED
LDH Growth Corp I Units
LDHAU
| $4.42M | ﹤0.01% |
448,917
-27,606
| -6% | -$274K |
|
|
AOMR
2964
Angel Oak Mortgage REIT
AOMR
$220M
| $4.42M | ﹤0.01% |
261,120
+73,940
| +40% | +$1.31M |
|
|
PDCO
2965
DELISTED
Patterson Companies, Inc.
PDCO
| $4.42M | ﹤0.01% |
146,696
-673,332
| -82% | -$20.4M |
|
|
SCOB
2966
DELISTED
ScION Tech Growth II Class A Ordinary Shares
SCOB
| $4.42M | ﹤0.01% |
453,444
+150,443
| +50% | +$1.46M |
|
2967
CDW
CDW
$18.9B
| $4.42M | ﹤0.01% |
+24,269
| New | +$4.58M |
|
2968
CALL
Apollo Global Management
APO
$72.4B
| $4.42M | ﹤0.01% |
+71,700
| New | +$4.31M |
|
2969
Clover Health Investments
CLOV
$2.2B
| $4.42M | ﹤0.01% |
597,589
-410,142
| -41% | -$3.51M |
|
|
HTO
2970
H2O America
HTO
$2.57B
| $4.41M | ﹤0.01% |
66,820
-27,617
| -29% | -$1.86M |
|
2971
Inspire Medical Systems
INSP
$1.45B
| $4.41M | ﹤0.01% |
18,945
-140,599
| -88% | -$29.3M |
|
2972
iShares MSCI USA Min Vol Factor ETF
USMV
$23.5B
| $4.41M | ﹤0.01% |
60,034
-3,246
| -5% | -$247K |
|
|
NXGN
2973
DELISTED
NextGen Healthcare, Inc. Common Stock
NXGN
| $4.41M | ﹤0.01% |
312,903
-60,570
| -16% | -$942K |
|
|
POND
2974
DELISTED
Angel Pond Holdings Corporation
POND
| $4.41M | ﹤0.01% |
+456,558
| New | +$4.4M |
|
2975
Arbutus Biopharma
ABUS
$857M
| $4.38M | ﹤0.01% |
+1,021,695
| New | +$3.4M |
|
Similar funds
Millennium Management's Q3 2021 Portfolio in Review
As of Q3 2021, Millennium Management held 7,698 positions worth $167B, up 2.3% from $163B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Millennium Management deployed $8.65B of net new capital in Q3 2021, opening 1,244 new positions and adding to 2,720 existing holdings. Its largest new stake was Sight Sciences: 1,577,092 shares worth $35.8M.
By sector, the portfolio is most concentrated in Technology at 7.4% of assets, down from 7.8% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Apple, an estimated $694M trimmed.
- Millennium Management's largest Q3 2021 buy was Sight Sciences: 1,577,092 shares worth $35.8M.
- Millennium Management added most to State Street SPDR S&P 500 ETF Trust in Q3 2021, an estimated $643M increase.
- Millennium Management's biggest Q3 2021 reduction was Apple, cutting an estimated $694M.
- Millennium Management fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $887M.
- Millennium Management's ten largest holdings make up 18% of its $167B portfolio in Q3 2021.
- Millennium Management opened 1,244 new positions and closed 981 in Q3 2021.
- Millennium Management's portfolio value rose 2.3% quarter-over-quarter to $167B.
Based on Millennium Management's 13F filing for Q3 2021, filed 15 Nov 2021.